Patients' satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors

• Asıl Yazarlar: Christina Darden (Yazar), Mark Price (Yazar), David Ray (Yazar), Grace Goldstein (Yazar), Diana Goss (Yazar), Lee Bennett (Yazar), Diana Garbinsky (Yazar), Ramya Thota (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: SpringerOpen, 2021-09-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background Long-acting somatostatin analogs (LA SSAs) are approved and recommended for the treatment of patients with advanced neuroendocrine tumors (NETs). Given the long duration of therapy and differences in administration routes, it is important to understand patients' experiences...